Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | AHR | P35869 | 2/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | CCR8 | P51685 | 1/20 | 0.40 |
| ▸ | METAP1 | P53582 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.40 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21742008 | 0.91 | SMN1; SMN2 (0.61) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL11681741 | 0.87 | L3MBTL1 (0.57) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL10044249 | 0.87 | SMN1; SMN2 (0.57) | SMN1; SMN2L3MBTL1AHRCHRM2 | |
| SCHEMBL946635 | 0.86 | SMN1; SMN2 (0.67) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL29965849 | 0.86 | SMN1; SMN2 (0.67) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL12717303 | 0.86 | SMN1; SMN2 (0.67) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL6921056 | 0.86 | SMN1; SMN2 (0.67) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL27997203 | 0.84 | SMN1; SMN2 (0.64) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL16230664 | 0.82 | SMN1; SMN2 (0.61) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL10442032 | 0.82 | SMN1; SMN2 (0.61) | SMN1; SMN2L3MBTL1AHRCHRM2BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2586893-A2 | Copper plating bath and method | Rohm and Haas Electronic Materials LLC (US) | 2013-05-01 | — | — | EP | claimed |
| US-20040029047-A1 | Micropattern forming material, micropattern forming method and method for manufacturing semiconductor device | RENESAS TECHNOLOGY CORP. (JP) | 2004-02-12 | — | — | US | claimed |
| EP-0957903-A4 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS INC (US) | 2002-10-09 | — | — | EP | claimed |
| US-20020141952-A1 | Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues | APPLIED GENETICS INCORPORATED DERMATICS | 2002-10-03 | — | — | US | claimed |
| EP-0957903-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | Codon Pharmaceuticals, Inc. (US) | 1999-11-24 | — | — | EP | claimed |
| US-5990177-A | CYCLIC AND ACYCLIC MONO-, DI- AND TRIALCOHOLS AS STIMULANTS TO TREAT DISEASES MEDIATED BY DEFICIENCIES IN THE NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE/PROTEIN KINASE G SIGNAL TRANSDUCTION PATHWAY; CARDIOVASCULAR; SKIN; NERVOUS SYSTEM | CODON PHARMACEUTICALS, INC. (US) | 1999-11-23 | — | — | US | claimed |
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | claimed |
| WO-1998055085-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS, INC. (US) | 1998-12-10 | — | — | WO | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1998011882-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS, INC. (US) | 1998-03-26 | — | — | WO | claimed |
| CN-108884030-B | Improved labeling of nucleophiles using bipyridines | 安捷伦科技有限公司 | 2022-06-28 | — | — | CN | disclosed |
| US-8454815-B2 | Plating bath and method | ROHM AND HAAS ELECTRONICS MATERIALS LLC (US) | 2013-06-04 | — | — | US | disclosed |
| EP-2586893-A2 | Copper plating bath and method | Rohm and Haas Electronic Materials LLC (US) | 2013-05-01 | — | — | EP | disclosed |
| US-20130098770-A1 | PLATING BATH AND METHOD | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2013-04-25 | — | — | US | disclosed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | disclosed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | disclosed |
| WO-1998011882-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS, INC. (US) | 1998-03-26 | — | — | WO | disclosed |
| US-5009980-A | Polyvinylpyridines, polyaminostyrenes and aromatic nitrogen compounds, such as bipyridines or anilines | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-04-23 | — | — | US | disclosed |
| EP-0376305-A2 | Aromatic nitrogen-containing compounds as adjuvants for electrostatic liquid developers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020141952-A1 | Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues | TYR, MITF, MC1R | SMN1; SMN2 3675/4885L3MBTL1 864/4885AHR 443/4885 |
| US-20130098770-A1 | PLATING BATH AND METHOD | AOC1, PNPO, AOC3 | SMN1; SMN2 854/4885L3MBTL1 3439/4885AHR 3121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.